1. Home
  2. ATNM vs INLX Comparison

ATNM vs INLX Comparison

Compare ATNM & INLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.12

Market Cap

45.2M

Sector

Health Care

ML Signal

HOLD

Logo Intellinetics Inc.

INLX

Intellinetics Inc.

N/A

Current Price

$8.00

Market Cap

36.5M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ATNM
INLX
Founded
2000
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
45.2M
36.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ATNM
INLX
Price
$1.12
$8.00
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
115.7K
3.6K
Earning Date
03-30-2026
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$90,000.00
$16,539,674.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$15.82
P/E Ratio
N/A
N/A
Revenue Growth
11.11
N/A
52 Week Low
$1.03
$7.50
52 Week High
$2.41
$15.72

Technical Indicators

Market Signals
Indicator
ATNM
INLX
Relative Strength Index (RSI) 33.16 45.82
Support Level $1.15 $7.95
Resistance Level $1.20 $8.51
Average True Range (ATR) 0.06 0.09
MACD -0.01 0.03
Stochastic Oscillator 6.24 23.88

Price Performance

Historical Comparison
ATNM
INLX

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.

Share on Social Networks: